How many institutions held FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value in Q4 2021?

26 institutional investors reported FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value for Q4 2021. Use the holders table for investor-level position and value details.

FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)

Q: What does CUSIP 31447P100 represent in this 13F holders report?

CUSIP 31447P100 is the security identifier for FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value used to aggregate holder disclosures.

CUSIP: 31447P100

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Shares, no par value
Shares outstanding: 34,763,175
Total 13F shares: 11,346,536
Share change: -310,983
Total reported value: $49,924,524
Put/Call ratio: 89%
Price per share: $4.40
Number of holders: 26
Value change: -$2,427,096
Number of buys: 11
Number of sells: 15

Quarterly Holders Quick Answers

What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 31447P100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Southpoint Capital Advisors LP	13F	Company	12%	4,077,214	$38,407,000	—	30 Sep 2021	13F
Sonic Fund II, L.P.	13F	Company	6.9%	2,407,357	$22,677,000	—	30 Sep 2021	13F
Avoro Capital Advisors LLC	13F	Company	4.8%	1,670,000	$15,731,000	—	30 Sep 2021	13F
683 Capital Management, LLC	13F	Company	3.2%	1,110,000	$10,456,000	—	30 Sep 2021	13F
Solas Capital Management, LLC	13F	Company	2.5%	867,857	$8,175,000	—	30 Sep 2021	13F
DG Capital Management, LLC	13F	Company	1.8%	618,451	$5,826,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.74%	257,621	$2,427,000	—	30 Sep 2021	13F
HARBERT FUND ADVISORS, INC.	13F	Company	0.5%	174,750	$1,646,000	—	30 Sep 2021	13F
Ergoteles LLC	13F	Company	0.26%	91,434	$861,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	0.16%	57,321	$541,000	—	30 Sep 2021	13F
HRT FINANCIAL LP	13F	Company	0.16%	55,935	$526,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.12%	40,977	$386,000	—	30 Sep 2021	13F
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV	13F	Company	0.12%	40,000	$377,000	—	30 Sep 2021	13F
Russell Investments Group, Ltd.	13F	Company	0.09%	31,728	$298,000	—	30 Sep 2021	13F
Hartford Financial Management Inc.	13F	Company	0.08%	28,848	$272,000	—	30 Sep 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.08%	26,942	$254,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.06%	19,909	$187,000	—	30 Sep 2021	13F
Belvedere Trading LLC	13F	Company	0.05%	17,790	$155,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	13,432	$127,000	—	30 Sep 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	0.04%	12,370	$117,000	—	30 Sep 2021	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.03%	10,994	$104,000	—	30 Sep 2021	13F
Ancora Advisors LLC	13F	Company	0.02%	6,000	$57,000	—	30 Sep 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	4,847	$45,000	—	30 Sep 2021	13F
BARCLAYS PLC	13F	Company	0.01%	2,648	$25,000	—	30 Sep 2021	13F
GROUP ONE TRADING LLC	13F	Company	0%	1,600	$15,000	—	30 Sep 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	1,400	$13,000	—	30 Sep 2021	13F
Wealth Quarterback LLC	13F	Company	0%	1,000	$10,000	—	30 Sep 2021	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	256	$2,412	—	30 Sep 2021	13F
SIMPLEX TRADING, LLC	13F	Company	0%	241	$1,000	—	30 Sep 2021	13F
ROYAL BANK OF CANADA	13F	Company	0%	94	$1,000	—	30 Sep 2021	13F
UBS Group AG	13F	Company	0%	64	$1,000	—	30 Sep 2021	13F
Shubh Goel	3/4/5	Chief Commercial Officer	— mixed-class rows	112,500 mixed-class rows	—	—	20 Dec 2021	3/4/5

Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q4 2021

As of 31 Dec 2021, FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,346,536 shares. The largest 10 holders included Southpoint Capital Advisors LP, Sonic Fund II, L.P., Avoro Capital Advisors LLC, DG Capital Management, LLC, Solas Capital Management, LLC, 683 Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, HARBERT FUND ADVISORS, INC., SUSQUEHANNA INTERNATIONAL GROUP, LLP, and BlackRock Inc.. This page lists 26 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

Holder diff

-4

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.